Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
03/02/2026
A Pfizer executive stated that the goal is to obtain the first approval for a series of potential obesity drugs in 2028.
Latest
5 m ago
Ant Financial CEO sent a letter to all employees, announcing the establishment of a "Large Model Technology Innovation Department".
6 m ago
Disney stated that Ed will serve as a senior consultant.
6 m ago
Disney appoints theme park head Josh D'Amaro as CEO.
7 m ago
Intercontinental Exchange Group: Getting ready to launch repurchase agreement clearing business later this year.
8 m ago
According to AI Express, Dongwu Securities issued a research report on February 3, giving Jinhuaxin Materials (920015.SH) a "buy" rating. The main reasons for the rating include: 1) A high-quality supplier in the ketone oxime industry; 2) The market size of hydroxylamine salts is rising, and the downstream market industry is expanding; 3) Strong technological innovation capabilities and abundant high-quality customer resources. (Daily Economic News)
See all latest